Product Information
DEXTROAMPH-AMPHET ER 37.5 MG CP is a generic product labeled by SpecGx LLC, priced at $8.2569 per EA under NDC 00406080701. Its NADAC has been published 115 times since Apr 17, 2024.
DEXTROAMPH-AMPHET ER 37.5 MG CP
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATEStrength
9.375; 9.375; 9.375; 9.375 mg/1; mg/1; mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406080701
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211546On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPH-AMPHET ER 37.5 MG CP has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.2569 per EA |
|---|---|
| All-time high | $8.8791 (Jul 16, 2025) |
| All-time low | $7.7685 (May 22, 2024) |
| 52-week high | $8.8791 |
| 52-week low | $8.2569 |
| Median price | $8.4743 |
| Average price | $8.4596 |
| Largest weekly change | +10.9% (Jun 19, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DEXTROAMPH-AMPHET ER 37.5 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPH-AMPHET ER 37.5 MG CP, manufactured by SpecGx LLC, is $8.2569 per EA (NDC 00406080701), effective Jun 24, 2026.
How has the price of DEXTROAMPH-AMPHET ER 37.5 MG CP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPH-AMPHET ER 37.5 MG CP has risen 4.7%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DEXTROAMPH-AMPHET ER 37.5 MG CP?
Since Apr 17, 2024, the NADAC for DEXTROAMPH-AMPHET ER 37.5 MG CP has ranged from a low of $7.7685 (May 22, 2024) to a high of $8.8791 (Jul 16, 2025), with a median of $8.4743 per EA.
Are there cheaper alternatives to DEXTROAMPH-AMPHET ER 37.5 MG CP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DEXTROAMPH-AMPHET ER 37.5 MG CP, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPH-AMPHET ER 37.5 MG CP?
DEXTROAMPH-AMPHET ER 37.5 MG CP (NDC 00406080701) is labeled by SpecGx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification